Normally absent in adult tissues, DLL3 is aberrantly expressed on the surface of approximately 80% of SCLC cells, where it functions as a cis-inhibitor of the Notch signaling pathway, preventing receptor activation and downstream transcription of genes such as HES1 and HEY1 [28,29]. Here, DLL3 is linked to small cell lung carcinoma.